Detalhe da pesquisa
1.
DNA methylation profiling of myelodysplastic syndromes and clinical response to azacitidine: A multicentre retrospective study.
Br J Haematol
; 204(5): 1838-1843, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38471524
2.
Long-term outcome of high risk patients with myelodysplastic syndromes or secondary acute myeloid leukemia receiving intensive chemotherapy.
Ann Hematol
; 97(12): 2325-2332, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30078145
3.
Effect of deferasirox + erythropoietin vs erythropoietin on erythroid response in Low/Int-1-risk MDS patients: Results of the phase II KALLISTO trial.
Eur J Haematol
; 2018 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29777631
4.
Cytogenetic clonal evolution in myelodysplastic syndromes is associated with inferior prognosis.
Cancer
; 123(23): 4608-4616, 2017 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28746789
5.
A retrospective study evaluating the impact of infectious complications during azacitidine treatment.
Ann Hematol
; 96(7): 1097-1104, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28474144
6.
Causes of death in 2877 patients with myelodysplastic syndromes.
Ann Hematol
; 95(6): 937-44, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27025507
7.
In patients with myelodysplastic syndromes with del(5q), factors other than age and sex contribute to the prognostic advantage, which diminishes over time.
Br J Haematol
; 170(5): 687-93, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25960152
8.
Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet.
Blood
; 122(17): 2943-64, 2013 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-23980065
9.
Impaired cytotoxicity associated with defective natural killer cell differentiation in myelodysplastic syndromes.
Haematologica
; 100(5): 643-52, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25682594
10.
Cellularity, characteristics of hematopoietic parameters and prognosis in myelodysplastic syndromes.
Eur J Haematol
; 95(3): 181-9, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25600827
11.
Imetelstat: Finally a disease-modifying treatment for lower-risk myelodysplastic syndromes?
Med
; 5(3): 184-186, 2024 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38460498
12.
Validation of a novel algorithm with a high specificity in ruling out MDS.
Int J Lab Hematol
; 46(3): 510-514, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38284270
13.
Comparison of cytomorphology and histomorphology in myelodysplastic syndromes.
Front Oncol
; 14: 1359115, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38665949
14.
Infectious Complications in Patients with Myelodysplastic Syndromes: A Report from the Düsseldorf MDS Registry.
Cancers (Basel)
; 16(4)2024 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38398198
15.
Iron rusting in the mitochondria?
Blood
; 128(15): 1907-1908, 2016 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-27737844
16.
Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up results.
Blood
; 117(4): 1141-5, 2011 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-21098399
17.
Serum hepcidin measured with an improved ELISA correlates with parameters of iron metabolism in patients with myelodysplastic syndrome.
Ann Hematol
; 92(12): 1617-23, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23842708
18.
The impact of age on the diagnosis and therapy of myelodysplastic syndromes: results from a retrospective multicenter analysis in Germany.
Eur J Haematol
; 91(6): 473-82, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24102637
19.
Myelodysplastic Syndromes: New Methods of Diagnosis, Prognostication, and Treatment
Dtsch Arztebl Int
; 120(12): 203-210, 2023 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36718105
20.
Molecular and clinical aspects relevant for counseling individuals with clonal hematopoiesis of indeterminate potential.
Front Oncol
; 13: 1303785, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38162500